BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20623635)

  • 1. Predictive models before and after radical prostatectomy.
    Capitanio U; Briganti A; Gallina A; Suardi N; Karakiewicz PI; Montorsi F; Scattoni V
    Prostate; 2010 Sep; 70(12):1371-8. PubMed ID: 20623635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A critical appraisal of logistic regression-based nomograms, artificial neural networks, classification and regression-tree models, look-up tables and risk-group stratification models for prostate cancer.
    Chun FK; Karakiewicz PI; Briganti A; Walz J; Kattan MW; Huland H; Graefen M
    BJU Int; 2007 Apr; 99(4):794-800. PubMed ID: 17378842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of nomograms with other methods for predicting outcomes in prostate cancer: a critical analysis of the literature.
    Shariat SF; Karakiewicz PI; Suardi N; Kattan MW
    Clin Cancer Res; 2008 Jul; 14(14):4400-7. PubMed ID: 18628454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inventory of prostate cancer predictive tools.
    Shariat SF; Karakiewicz PI; Margulis V; Kattan MW
    Curr Opin Urol; 2008 May; 18(3):279-96. PubMed ID: 18382238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative neural network using combined magnetic resonance imaging variables, prostate-specific antigen, and gleason score for predicting prostate cancer biochemical recurrence after radical prostatectomy.
    Poulakis V; Witzsch U; de Vries R; Emmerlich V; Meves M; Altmannsberger HM; Becht E
    Urology; 2004 Dec; 64(6):1165-70. PubMed ID: 15596191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The current state of brachytherapy nomograms for patients with clinically localized prostate cancer.
    Nguyen CT; Zelefsky MJ; Kattan MW
    Cancer; 2009 Jul; 115(13 Suppl):3121-7. PubMed ID: 19544540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can nomograms be superior to other prediction tools?
    Shariat SF; Capitanio U; Jeldres C; Karakiewicz PI
    BJU Int; 2009 Feb; 103(4):492-5; discussion 495-7. PubMed ID: 18990135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An updated catalog of prostate cancer predictive tools.
    Shariat SF; Karakiewicz PI; Roehrborn CG; Kattan MW
    Cancer; 2008 Dec; 113(11):3075-99. PubMed ID: 18823041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Undetectable ultrasensitive PSA after radical prostatectomy for prostate cancer predicts relapse-free survival.
    Doherty AP; Bower M; Smith GL; Miano R; Mannion EM; Mitchell H; Christmas TJ
    Br J Cancer; 2000 Dec; 83(11):1432-6. PubMed ID: 11076649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen activation inhibitor-1 improves the predictive accuracy of prostate cancer nomograms.
    Shariat SF; Park S; Trinh QD; Roehrborn CG; Slawin KM; Karakiewicz PI
    J Urol; 2007 Oct; 178(4 Pt 1):1229-36; discussion 1236-7. PubMed ID: 17698116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Can nomograms derived in the U.S. applied to German patients? A study about the validation of preoperative nomograms predicting the risk of recurrence after radical prostatectomy].
    Graefen M; Augustin H; Karakiewicz PI; Hammerer PG; Haese A; Palisaar J; Fernandez S; Noldus J; Erbersdobler A; Cagiannos I; Scardino PT; Kattan MW; Huland H
    Urologe A; 2003 May; 42(5):685-92. PubMed ID: 12750804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of a nomogram for prediction of side specific extracapsular extension at radical prostatectomy.
    Steuber T; Graefen M; Haese A; Erbersdobler A; Chun FK; Schlom T; Perrotte P; Huland H; Karakiewicz PI
    J Urol; 2006 Mar; 175(3 Pt 1):939-44; discussion 944. PubMed ID: 16469587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The probability of Gleason score upgrading between biopsy and radical prostatectomy can be accurately predicted.
    Capitanio U; Karakiewicz PI; Jeldres C; Briganti A; Gallina A; Suardi N; Cestari A; Guazzoni G; Salonia A; Montorsi F
    Int J Urol; 2009 May; 16(5):526-9. PubMed ID: 19389085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A validated strategy for side specific prediction of organ confined prostate cancer: a tool to select for nerve sparing radical prostatectomy.
    Graefen M; Haese A; Pichlmeier U; Hammerer PG; Noldus J; Butz K; Erbersdobler A; Henke RP; Michl U; Fernandez S; Huland H
    J Urol; 2001 Mar; 165(3):857-63. PubMed ID: 11176486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk stratification after radical prostatectomy in men with pathologically organ-confined prostate cancer using volume-weighted mean nuclear volume.
    Matsui Y; Utsunomiya N; Ichioka K; Ueda N; Yoshimura K; Terai A; Arai Y
    Prostate; 2005 Aug; 64(3):217-23. PubMed ID: 15712275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. External validation of a biomarker-based preoperative nomogram predicts biochemical recurrence after radical prostatectomy.
    Shariat SF; Walz J; Roehrborn CG; Zlotta AR; Perrotte P; Suardi N; Saad F; Karakiewicz PI
    J Clin Oncol; 2008 Mar; 26(9):1526-31. PubMed ID: 18349404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nomograms for bladder cancer.
    Shariat SF; Margulis V; Lotan Y; Montorsi F; Karakiewicz PI
    Eur Urol; 2008 Jul; 54(1):41-53. PubMed ID: 18207314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-operative percent free PSA predicts clinical outcomes in patients treated with radical prostatectomy with total PSA levels below 10 ng/ml.
    Shariat SF; Abdel-Aziz KF; Roehrborn CG; Lotan Y
    Eur Urol; 2006 Feb; 49(2):293-302. PubMed ID: 16387412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of survival after radical cystectomy for invasive bladder carcinoma: risk group stratification, nomograms or artificial neural networks?
    el-Mekresh M; Akl A; Mosbah A; Abdel-Latif M; Abol-Enein H; Ghoneim MA
    J Urol; 2009 Aug; 182(2):466-72; discussion 472. PubMed ID: 19524972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validity of the CAPRA score to predict biochemical recurrence-free survival after radical prostatectomy. Results from a european multicenter survey of 1,296 patients.
    May M; Knoll N; Siegsmund M; Fahlenkamp D; Vogler H; Hoschke B; Gralla O
    J Urol; 2007 Nov; 178(5):1957-62; discussion 1962. PubMed ID: 17868719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.